Candriam SCA’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-380,000
| Closed | -$11.7M | – | 694 |
|
|
2024
Q1 | $11.7M | Buy |
380,000
+81,000
| +27% | +$2.5M | 0.08% | 240 |
|
|
2023
Q4 | $12.1M | Buy |
299,000
+54,000
| +22% | +$2.18M | 0.08% | 231 |
|
|
2023
Q3 | $6.46M | Sell |
245,000
-40,000
| -14% | -$1.05M | 0.05% | 284 |
|
|
2023
Q2 | $4.9M | Hold |
285,000
| – | – | 0.04% | 335 |
|
|
2023
Q1 | $4.35M | Buy |
285,000
+188,756
| +196% | +$2.88M | 0.03% | 396 |
|
|
2022
Q4 | $733K | Buy |
96,244
+469
| +0.5% | +$3.57K | ﹤0.01% | 758 |
|
|
2022
Q3 | $952K | Sell |
95,775
-306,137
| -76% | -$3.04M | 0.01% | 717 |
|
|
2022
Q2 | $3.65M | Hold |
401,912
| – | – | 0.03% | 376 |
|
|
2022
Q1 | $4.08M | Hold |
401,912
| – | – | 0.03% | 391 |
|
|
2021
Q4 | $6.7M | Sell |
401,912
-53,373
| -12% | -$890K | 0.04% | 306 |
|
|
2021
Q3 | $21.3M | Hold |
455,285
| – | – | 0.15% | 166 |
|
|
2021
Q2 | $27.8M | Buy |
+455,285
| New | +$27.8M | 0.19% | 124 |
|